概括
这项关于门置换手术的研究发现,将其与软静脉旁路移植相结合并没有增加医院死亡率. 在这些心脏手术的大部分幸存者中,发现了症状的改善.
科学领域:
- 心血管外科心血管外科
- 心脏门手术 心脏门手术
- 冠状动脉绕道移植冠状动脉绕道移植
背景情况:
- 大动脉置换 (AVR) 和心心置换 (MVR) 是关键的心脏手术.
- 门置换与软静脉绕道移植 (SVBG) 的结合具有独特的外科考虑.
- 了解联合手术的结果对于患者管理至关重要.
研究的目的:
- 评估接受AVR或MVR与SVBG相结合的患者的医院死亡率和术后心肌损伤率.
- 为了比较组合门更换和单独门更换的绕道移植的结果.
- 评估这些联合心脏手术后的长期生存和症状改善.
主要方法:
- 在1970年5月至1974年1月期间,对59名接受AVR或MVR结合SVBG的患者进行了回顾性分析.
- 数据收集包括医院死亡率,手术后心肌损伤的发生率和晚期死亡率.
- 分析手术技术和心肌保护方法 (冠状动脉输液与低温缺血性停止).
主要成果:
- 对于AVR的医院死亡率为4.7%,对于MVR是6.3%.
- 术后心肌损伤发生在21%的AVR患者和6.2%的MVR患者中.
- 晚期死亡率为AVR的16.3%,MVR的25%;大多数幸存者观察到症状改善.
结论:
- 结合AVR或MVR与SVBG的操作死亡率与单独的门置换相比较.
- 手术技术和心肌维护的变化没有显著影响医院死亡率或心肌损伤.
- 这项研究表明,结合门和绕道手术可以在可接受的早期和晚期结果下进行.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...


